List of news
Filtered by the Research news category.
-
Featured news story
Published on: 21 July 2025
A clinical trial for patients newly diagnosed with glioblastoma, an aggressive form of brain cancer, has opened at the NIHR UCLH Clinical Research Facility based in the National Hospital for Neurology and Neurosurgery.
-
Category: Research news
Published on: 31 July 2025
UCLH has been selected as the lead site in Great Britain for Neuralink’s GB-PRIME study, a clinical investigation for Neuralink’s brain-computer interface (BCI).
-
Category: Research news
Published on: 30 July 2025
UCLH has recruited the first participant in the UK to a study looking at a new investigational drug for patients with a condition affecting the blood vessels in the brain called cerebral amyloid angiopathy (CAA).
-
Category: Research news
Published on: 21 July 2025
Initial results from an early phase study testing the safety and efficacy of a new drug for multiple myeloma have shown a 100 per cent overall response rate in patients with recurrent disease who were given the clinically recommended dose of the investigational drug.
-
Category: Research news
Published on: 15 July 2025
Learn more about how UCLH celebrated Research Open Day this month.
-
Category: Research news
Published on: 04 June 2025
The first ever treatment for the rare neurodegenerative disease Friedreich’s ataxia – for which UCLH and UCL led the UK trial – has been approved for use in the UK by the medicines’ regulator.
-
Category: Research news
Published on: 28 May 2025
Congratulations to UCLH’s Dr Mary McCormack who has been listed as one of the 100 most influential people in health in the world by TIME magazine.
-
Category: Research news
Published on: 19 May 2025
A new research project spearheaded by the CCTU at UCLH is trying to make more places on clinical trials available to young cancer patients aged between 16 and 24 years.
-
Category: Research news
Published on: 19 May 2025
A new research project aims to improve understanding of the unique impact of health conditions on UK Black communities.
-
Category: Research news
Published on: 02 May 2025
Newly reported updated results of a study from UCLH and UCL highlights the powerful benefits of a targeted immune therapy for a type of slow-growing blood cancer.
-
Category: Research news
Published on: 23 April 2025
UCLH has recruited the first participant in Europe to a global clinical trial for adults with Myotonic Dystrophy Type 1 (DM1)- a genetic condition and type of muscular dystrophy that causes progressive muscle weakness and wasting.
